Latest

Inland Homes – profit upgrades expected with the figures later this month

Mark Watson-Mitchell opens 2022 with a look at this housebuilder ahead of its 2021 final results.

What Investors Need to Know about 2022 – Part I – the UK

In 2022, in financial markets and in UK politics, the fundamental principle that risk management trumps risk aversion will be…

Don’t get sucked in by the New Year tips

Whatever you do, please do not get sucked into any of the media ‘end-of-the-year’ share tips – unless you have…

Evil Diaries: Different expressions of intangibility

Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.

Do Vodafone and Legal & General’s high yields appeal as inflation soars to a 10-year high?

Robert Stephens, CFA, discusses the prospects for two FTSE 100 income shares.

The City is surviving − even thriving

At the end of the first year of life outside the EU – one doubly traumatised by a second year…

Why 2022 could be a year of uncertainty, and opportunity, for the FTSE 100

Robert Stephens, CFA, considers the outlook for the FTSE 100 in 2022

Is it time to replace growth and ‘meme’ for value?

Growth, as an investment style, has completely outperformed value during the last 10 years.

Hybridan Small Cap Feast

A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.

Futura Medical – ready to go up again

Does Futura Medical offer a solid investment opportunity for 2022?